Vcanbio Cell & Gene Engineering Corp., Ltd (SHA:600645)

SHA:600645 Revenue

Vcanbio Cell & Gene Engineering Corp., had revenue of 317.34M CNY in the quarter ending March 31, 2026, a decrease of -9.54%. This brings the company's revenue in the last twelve months to 1.42B, down -7.59% year-over-year. In the year 2025, Vcanbio Cell & Gene Engineering Corp., had annual revenue of 1.45B, down -8.23%.

• Revenue (ttm): 1.42B
• Revenue Growth: -7.59%
• P/S Ratio: 6.38
• Revenue / Employee: 734.62K
• Employees: 2,014
• Market Cap: 9.07B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.45B	-130.47M	-8.23%
Dec 31, 2024	1.59B	-4.30M	-0.27%
Dec 31, 2023	1.59B	34.84M	2.24%
Dec 31, 2022	1.55B	19.56M	1.27%
Dec 31, 2021	1.54B	216.43M	16.41%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 27, 2026

Data Sources Report a data error